Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

BTMD

biote Corp.

Healthcare · Pharmaceuticals

$1.22Sep 25, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

biote Corp. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -9% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue -9% YoY in Q2 FY2026

Pipeline evidence · 0d ago

BTMD's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on BTMD.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full BTMD earnings analysis

Reported figures for biote Corp. — research only, not investment advice.

Revenue YoY
-9.5%
EPS YoY
-330.0%

Latest Intelligence

Updated

What happened recently for biote Corp. (BTMD) — events, not interpretation.

Event
Reported Q2 2026 revenue -10% YoY.
Also
Last session September 25, 2026 at $1.22.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

biote Corp. (BTMD)

Healthcare · Pharmaceuticals

Investment Snapshot above is the primary AlphaOS analysis for biote Corp. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$36.15M
Revenue:
$44.23M

BTMD earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow biote Corp. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.